Injury - 2026-03-25 - Journal Article
Soft bandage vs rigid immobilisation in pediatric distal radius torus fractures: A cost and patient burden analysis - A retrospective cohort study.
Kaya S, Pür B, Karabak B, Dursun MA
Topics
Key Takeaway
Soft bandage management of pediatric distal radius torus fractures reduced total societal cost by 33–47% compared to short and long arm splints ($23.46 vs $34.82 vs $44.06), with a projected $7,773 combined saving over the study period.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study compared outpatient visit frequency, imaging burden, and direct/indirect costs across three immobilization strategies (soft bandage, short arm splint, long arm splint) for pediatric distal radius torus fractures at a single tertiary center. Soft bandage patients had fewer visits (median 2 vs 3 vs 4), fewer radiographs (median 2 vs 3 vs 3), and lower total societal costs ($23.46 vs $34.82 vs $44.06; p<0.001). Immobilization material cost was the single most discriminating cost driver, differing 8.7-fold between soft bandage and long arm splint.
Key Limitation
The study was conducted at a single center in Turkey using national minimum wage for caregiver time valuation, limiting direct cost generalizability to healthcare systems with different reimbursement structures or wage rates.
Original Abstract
BACKGROUND
Distal radius torus fractures (DRTFs) are among the most common pediatric skeletal injuries, yet management strategies vary widely between institutions. Repeated outpatient visits and imaging associated with rigid immobilisation impose direct medical costs and indirect burdens on families that are rarely quantified. This study aimed to compare outpatient revisit frequency, imaging burden, direct medical costs, indirect caregiver costs, and total societal costs among children with DRTFs managed with soft bandage (SB), short arm splint (SAS), or long arm splint (LAS).
METHODS
A retrospective cohort study was conducted at a tertiary orthopedic centre. Consecutive patients aged 0-16 years with a radiographically confirmed DRTF presenting between 2024 and 2025 were stratified by immobilisation type: SB (n = 69), SAS (n = 492), and LAS (n = 106). Direct costs comprised outpatient visit fees, imaging, and immobilisation material costs derived from National Social Security Institution reimbursement tariffs. Indirect costs were estimated using the human capital approach, valuing caregiver time at the 2025 national minimum wage (0.053 USD/minute). Between-group comparisons were performed using the Kruskal-Wallis and Mann-Whitney U tests.
RESULTS
A total of 667 patients were included (mean age 8.6 ± 3.9 years; 67.0% male). SB was associated with significantly fewer outpatient visits (median 2 vs 3 vs 4; p < 0.001), fewer radiographs (median 2 vs 3 vs 3; p < 0.001), and lower total caregiver time (median 120 vs 176 vs 204 min; p = 0.005). Mean direct cost was lower in the SB group ($12.35 vs $19.74 vs $27.00; p < 0.001), as were indirect ($11.11 vs $15.08 vs $17.06; p = 0.005) and total societal costs ($23.46 vs $34.82 vs $44.06; p < 0.001). Immobilisation material cost was the most discriminating component, differing 4.2-fold between SB and SAS and 8.7-fold between SB and LAS. Had all splint-treated patients been managed with SB, a combined societal saving of $7773 could have been achieved over the study period.
CONCLUSION
SB immobilisation was associated with fewer revisits, reduced imaging burden, and lower direct and indirect costs compared with rigid splinting, supporting its adoption as a cost-effective strategy in resource-conscious healthcare settings.